Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine

Pediatric Infectious Disease Journal

Volumn 26, Issue 2, 2007, Pages 107-115

  Zeman, Alenka M ^a   Holmes, Tyson H ^a   Stamatis, Shaye ^a   Tu, Wenwei ^a   He, Xiao Song ^a   Bouvier, Nancy ^a   Kemble, George ^b   Greenberg, Harry B ^a   Lewis, David B ^a   Arvin, Ann M ^a   Dekker, Cornelia L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDIMMUNE   (United States)

Author keywords

Antibody; Children; Influenza vaccine; T cells

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; TRIPLE VACCINE;

ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; EVALUATION; FEMALE; FLOW CYTOMETRY; GROUPS BY AGE; HEMAGGLUTINATION INHIBITION; HONG KONG; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOASSAY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H3N2; LYMPHOCYTE ACTIVATION; MALE; PANAMA; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VIRUS STRAIN; VIRUS TITRATION;

AGE FACTORS; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INTERFERON TYPE II; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; NEUTRALIZATION TESTS; STATISTICS; T-LYMPHOCYTES; VACCINES, INACTIVATED;

EID: 33846560620     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000253251.03785.9b     Document Type: Article

References (28)

1. Couch RB. Prevention and treatment of influenza. N Engl J Med. 2000;343:1778-1787.
2. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342:232-239.
3. Rojo J, Ruiz-Contreras J, Fernández M, Marín M, Folgueira L. Influenza-related hospitalizations in children younger than three years of age. Pediatr Infect Dis J. 2006;25:596-601.
4. Poehling K, Edwards K, Weinberg G, et al. The underrecognized burden of influenza in young children. N Engl J Med. 2006;355:31-40.
5. Hurwitz ES, Haber M, Chang A, et al. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA. 2000;284:1677-1682.
6. Gruber WC, Taber LH, Glezen WP, et al. Live attenuated and inactivated influenza vaccine in school-age children. Am J Dis Child. 1990;144:595-600.
7. Bridges CB, Fukuda K, Uyeki TM, Cox NJ, Singleton JA. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2002;51:1-31.
8. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2005;54:1-40.
9. Estimated influenza vaccination coverage among adults and children - United States, September 1, 2004-January 31, 2005. MMWR Morb Mortal Wkly Rep. 2005;54:304-307.
10. Haining WN, Evans JW, Seth NP, et al. Measuring T cell immunity to influenza vaccination in children after haematopoietic stem cell transplantation. Br J Haematol. 2004;127:322-325.
11. Kumagai T, Nagai K, Okui T, et al. Poor immune responses to influenza vaccination in infants. Vaccine. 2004;22:3404-3410.
12. Gross PA, Denning CR, Gaerlan PF, et al. Annual influenza vaccination: Immune response in patients over 10 years. Vaccine. 1996;14:1280-1284.
13. Keitel WA. Repeated immunization of children with inactivated and live attenuated influenza virus vaccines: Safety, immunogenicity, and protective efficacy. Seminars in Pediatric Infectious Diseases. 2002;13:112-119.
14. Gross PA, Sperber SJ, Donabedian A, et al. Paradoxical response to a novel influenza virus vaccine strain: The effect of prior immunization. Vaccine. 1999;17:2284-2289.
15. He XS, Mahmood K, Maecker HT, et al. Analysis of the frequencies and of the memory T cell phenotypes of human CD8+ T cells specific for influenza A viruses. J Infect Dis. 2003;187:1075-1084.
16. He XS, Draghi M, Mahmood K, et al. T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus. J Clin Invest. 2004;114:1812-1819.
17. The 1998-1999 WHO Influenza Reagent Kit for the Identification of Influenza Isolates. Atlanta: Centers for Disease Control and Prevention; 1998.
18. Belshe RB, Gruber WC, Mendelman PM, et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis. 2000;181:1133-1137.
19. Harrell FE Jr. Regression Modeling Strategies With Applications to Linear Models, Logistic Regression and Survival Analysis. New York: Springer-Verlag; 2001.
20. Sokal RR, Rohlf FJ. Biometry, 2nd ed. New York: WH Freeman and Co; 1981:42-43.
21. McCulloch C, Searle S. Generalized, Linear, and Mixed Models. New York: John Wiley & Sons, Inc; 2001.
22. Carmer SG, Walker WM. Baby Bear's dilemma: A statistical tale. Agronomy Journal. 1982;74:122-124.
23. 2003-2004 U.S. influenza season summary. 2004 [CDC web site]. Available at: www.cdc.gov/flu/weekly/weeklyarchives2003-2004/03-04summary.htm.
24. Flu Activity Reports [CDC web site]. Available at: www.cdc.gov/flu/ weekly/fluactivity.htm.
25. Cox RJ, Brokstad KA, Ogra P. Influenza virus: Immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol. 2004;59:1-15.
26. Mitchell DK, Ruben FL, Gravenstein S. Immunogenicity and safety of inactivated influenza virus vaccine in young children in 2003-2004. Pediatr Infect Dis J. 2005;24:925-927.
27. Schmitt-Grohé S, Banzhoff A, Klaassen B, Zielen S. [Safety of an influenza-split-vaccine in children. ] Klin Pediatr. 2001;213:338-342.
28. Ruben FL. Inactivated influenza virus vaccines in children. Clin Infect Dis. 2004;38:678-688.